Group 1 - The Ministry of Industry and Information Technology and other departments issued an implementation opinion to promote the high-quality development of the technology service industry, focusing on research and development, technology transfer, and enterprise incubation [1] - The State Administration of Foreign Exchange reported a continued positive trend in foreign investment in RMB assets, with a net increase of $10.9 billion in domestic bonds in April, and a shift to net buying in domestic stocks by foreign investors in late April [1] - TSMC plans to increase prices for its advanced process nodes, with a 10% price hike for 2nm wafers and a potential increase of up to 30% for its 4nm manufacturing node [1] - The National Financial Supervision and Administration Bureau approved Xinhua Insurance's participation in the third batch of long-term investment reform pilot projects, aiming to expedite the entry of long-term funds into the market [1] Group 2 - Kweichow Moutai's shareholders' meeting approved a profit distribution plan for 2024, proposing a dividend of 276.24 yuan per share [2] - Liren Lizhuang reported a cumulative transaction amount (GMV) of only 4.006 million yuan for its product in Q1 2025 [2] - Zhongyida stated that its production capacity remains stable with no new construction plans [2] - Weir Shares plans to change its stock name from "Weir Shares" to "Haowei Group" [2] - Wan'an Technology confirmed there are no significant undisclosed matters [2] - Ningbo Shipping's stock price has been highly volatile recently, indicating a high risk of speculation [2] - Lianyungang reported that its production and operational activities are normal, with no significant changes in industry policies [2]

证券代码：605136 证券简称：丽人丽妆 公告编号：2025-030 上海丽人丽妆化妆品股份有限公司 股票交易风险提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担法律责任。 重要内容提示： 上海丽人丽妆化妆品股份有限公司（以下简称"公司"或 "丽人丽妆"）股票价格已经于 2025 年 5 月 15 日、5 月 16 日 连续两个交易日内日收盘价格涨幅偏离值累计超过 20%。根据上 海证券交易所的相关规定，属于股票交易异常波动情形，公司已 于 2025 年 5 月 17 日披露了《股票交易异常波动公告》（公告编 号：2025-029 号）。2025 年 5 月 19 日，公司股票再次涨停，换 手率达到 19.87%，敬请广大投资者理性决策，注意投资风险。 相关媒体报道、市场传闻说明及风险提示：就目前市场上 较为关注的"麦角硫因"成分，公司销售的含有"麦角硫因"成 分的"千金极光饮"产品 2025 年 1 季度累计成交金额（GMV） 仅为 400.60 万元，销售收入整体占比不到 1%，对于公司日常经 营及整体业绩影响很小。 ...

大消费概念持续活跃 丽人丽妆3连板 智通财经5月19日电，午后大消费概念持续活跃，医美、宠物经济方向领涨，丽人丽妆走出3连板，拉芳 家化、源飞宠物涨停，天元宠物、锦波生物、百龙创园、路斯股份股价创出历史新高。消息面上，据粤 开证券统计，国内消费医疗对应万亿级市场规模。医美领域市场规模预计2025年达到3529亿元。 ...

Group 1 - The Ministry of Commerce has issued the third batch of best practice cases for the national service industry expansion pilot, focusing on replicable and promotable experiences for service industry development [1] - The best practices include 11 innovative measures across three areas: industrial ecosystem construction, international cooperation, and regional collaboration [1] - The measures reflect collaborative openness and integrated innovation in key industries such as culture, technology, and healthcare [1] Group 2 - The State Administration for Market Regulation is soliciting public opinions on the revised draft regulations to curb the abuse of administrative power that restricts competition [2] - The National Bureau of Statistics reported that the average annual salary for urban non-private and private sector employees in 2024 will be CNY 124,110 and CNY 69,476, respectively [2] Group 3 - The Ministry of Finance and the Financial Regulatory Bureau have announced a push for the digitalization of bank confirmations to enhance efficiency and security [3] - The notification emphasizes the importance of increasing the number of entities accessing the bank confirmation platform [3] Group 4 - The Ministry of Commerce and the National Development and Reform Commission have revised the "Catering Industry Promotion and Management Measures," adding provisions to encourage international cooperation and digital development [4] - The revised measures include 25 articles aimed at promoting high-quality development in the catering industry [4] Group 5 - The State-owned Assets Supervision and Administration Commission announced personnel changes in 10 central enterprises, including leadership appointments and removals [5][6] Group 6 - The China Securities Regulatory Commission encourages private equity funds to participate in mergers and acquisitions of listed companies, with adjustments to lock-up periods for investments [7] - The Shenzhen Stock Exchange is monitoring stocks with abnormal price fluctuations, including "ST Yushun" and "ST Jiajia" [8] Group 7 - The Shenzhen Stock Exchange will host the 2025 Global Investor Conference to showcase the investment value of Chinese assets and the A-share market [9] Group 8 - The Ministry of Industry and Information Technology is accelerating the development of 5G-A and 6G technologies to support modern industrial systems [13] - The National Data Bureau aims for the core value added of the digital economy to exceed 10% of GDP by the end of 2025 [14] Group 9 - The Ministry of Industry and Information Technology reported that China has built the world's largest and most advanced information and communication network, with 5G applications covering 86 of 97 national economic categories [15] Group 10 - Binhai Energy plans to acquire 100% equity of Cangzhou Xuyang Chemical Co., Ltd., with the stock expected to resume trading on May 19, 2025 [17] - The automotive industry is set to benefit from a significant release of funds due to a recent reserve requirement ratio cut, potentially exceeding CNY 1 trillion [18] Group 11 - Xiaomi's President revealed that products using the self-developed "Xuanjie" chip will extend beyond smartphones [21] - Huamin Co. and Tiantai Robotics signed a strategic cooperation agreement to advance the robotics industry [21] Group 12 - Xiangzi High-Tech announced the sale of an 80% stake in Heilongjiang Yunfeng Automobile Co., Ltd. for CNY 24.6 million, aiming to restructure its fuel vehicle business [22] - ST Kexin has successfully removed its delisting risk warning and will change its stock name to Kexin Development [23] Group 13 - *ST Aonong has received approval to remove its delisting risk warning, with its stock name changing to Aonong Biological [24][25] - Jianghan New Materials plans to repurchase shares worth CNY 200 million to CNY 400 million [26] Group 14 - Siyuan Electric intends to repurchase shares worth CNY 300 million to CNY 500 million [27] - Liren Lizhuang reported that products containing "Mikang Sulfur" have a minimal impact on overall business performance [28] Group 15 - Jinhe Biological's controlling shareholder plans to reduce its stake by up to 3% [29] - Guanghui Energy announced the transfer of 15.03% of its shares to two insurance companies [30] Group 16 - Tailing Microelectronics reported a reduction in the National Big Fund's shareholding to 6.95% [31] - AVIC High-Tech plans to invest CNY 918 million to enhance its capabilities in aviation composite materials [32]

以下文章来源于e公司 ，作者证券时报 严翠 e公司 . e公司，证券时报旗下专注上市公司新媒体产品，立志打造A股上市公司资讯第一平台。提供7x24小时 上市公司标准化快讯，针对可能影响上市公司股价的主题概念、行业事件及时采访二次解读，从投资者 需求出发，直播上市公司有价值的活动、会议。 近日，随着75岁的科伦药业董事长刘革新公开秀其紧实的肌肉，并自称长期服用麦角硫因，A股麦角硫因 概念开始异军突起，丽人丽妆、川宁生物、拓新药业、金达威、福瑞达等多只个股大涨。 丽人丽妆（605136）股价已连续两个交易日涨停。5月16日晚，丽人丽妆公告，公司股票价格于2025年5月15 日、5月16日连续两个交易日内日收盘价格涨幅偏离值累计超过20%。根据上海证券交易所的相关规定，属于 股票交易异常波动情形。 | | 复权 叠加 多股 统计 | 画线 标记 +自选 返回 | | 丽人丽妆 605136 | | | | --- | --- | --- | --- | --- | --- | --- | | | | <> 9.50 - 9.43 | | 9.43 0.86 10.04% | | -0.08% | | | | 9.0 ...

Core Viewpoint - Shanghai Liren Lizhuang Cosmetics Co., Ltd. experienced a significant stock price fluctuation, with a cumulative closing price increase of over 20% on May 15 and 16, 2025, which is classified as an abnormal trading situation according to Shanghai Stock Exchange regulations [2][3]. Group 1: Stock Trading Situation - The company's stock price showed a cumulative increase of over 20% on May 15 and 16, 2025, indicating abnormal trading activity [2][3]. - The actual fluctuation of the stock price, after excluding the overall market and sector factors, was relatively large [10]. Group 2: Company Operations and Major Events - The company confirmed that its daily operations are normal, and there have been no significant changes in the market environment or industry policies [4]. - There are no undisclosed major events affecting the stock price, including significant asset restructuring, share issuance, or major business collaborations [5][8]. Group 3: Product and Revenue Impact - The product containing "ergothioneine," such as the self-owned brand Meiyitang's oral product "Qianjin Jiguang Drink," is primarily positioned for skin conditioning and beauty enhancement, with ergothioneine being a minor additive [6]. - The revenue from products containing "ergothioneine" constitutes a very low percentage of the company's overall revenue, having minimal impact on daily operations and overall performance [7][10].

Group 1 - The concept of ergot sulfur has gained popularity, leading to significant stock price movements among related companies, with some experiencing a daily limit increase [1][3] - Kelong Pharmaceutical has been actively promoting ergot sulfur, with its chairman showcasing the product's potential in an advertisement, which has contributed to the surge in related stocks [1][2] - Several companies have responded to investor inquiries regarding their involvement with ergot sulfur, indicating that the revenue from products containing this ingredient is currently low and has minimal impact on overall performance [3] Group 2 - Kelong Pharmaceutical has been focusing on the health industry for seven years, emphasizing the commercialization of ergot sulfur as a key growth factor [2] - Other companies, such as Haizheng Pharmaceutical and Wanbang Pharmaceutical, are also exploring the potential applications of ergot sulfur, with ongoing research and development efforts [3]

智通财经5月16日晚间新闻精选 3、香港恒生指数将加入美的集团和中通快递。比亚迪将加入香港恒生科技指数，剔除阅文集团。 4、易方达公告，知名基金经理张坤因工作调整不再担任副总经理的高管职务，未来将专注于投资管理 工作。 1、证监会鼓励私募基金参与上市公司并购重组，首次建立简易审核程序；首次调整发行股份购买资产 的监管要求；首次建立分期支付机制；首次引入私募基金"反向挂钩"安排。 5、金力泰：董事会不同意股东提议召开临时股东大会。20CM两连板拓新药业：伊沃斯于2025年3月14 日至5月15日累计减持131.28万股。泰凌微：国家大基金持股比例降至6.95%。2连板丽人丽妆：麦角硫 因产品收入占比很低。隧道股份：控股股东拟2.5亿元-5亿元增持公司股份。宁德时代公布H股发售价： 厘定为每股H股263.00港元。 2、多位公募业内人士表示，近日关于公募考核基准导致市场调仓的有关分析不准确、不专业，缺乏基 本常识和依据。 ...

Core Viewpoint - Shanghai Liren Lizhuang Cosmetics Co., Ltd. experienced a significant stock price fluctuation, with a cumulative closing price increase exceeding 20% over two consecutive trading days on May 15 and May 16, 2025, which is classified as an abnormal trading situation according to Shanghai Stock Exchange regulations [1][2]. Group 1: Stock Trading Abnormalities - The company's stock price showed a cumulative closing price increase of over 20% on May 15 and May 16, 2025, indicating abnormal trading activity [1][2]. - The company conducted a self-examination and confirmed that there are no undisclosed significant information affecting the stock price [2]. Group 2: Business Operations - The company's daily operations are reported to be normal, with no significant changes in market environment or industry policies [2]. - The company verified with its controlling shareholder that there are no undisclosed major events affecting stock price fluctuations, including major asset restructuring or significant business cooperation [2]. Group 3: Product Information - The product containing "ergothioneine," specifically the self-owned brand Meiyitang's oral product "Qianjin Jiguang Drink," has a low sales revenue contribution to the overall business, thus having minimal impact on daily operations and overall performance [2][3]. - The "ergothioneine" is a minor auxiliary additive in the product, primarily aimed at skin conditioning and beauty enhancement [2]. Group 4: Board Statements - The board of directors confirmed that there are no undisclosed matters that should be disclosed according to the Shanghai Stock Exchange's listing rules, and previous disclosures do not require correction or supplementation [4]. - The company emphasizes that all information should be based on disclosures made in designated media outlets [4].

上海丽人丽妆化妆品股份有限公司（以下简称"公司"或 "丽人丽妆"）股票价格于 2025 年 5 月 15 日、5 月 16 日连续 两个交易日内日收盘价格涨幅偏离值累计超过 20%。根据上海证 券交易所的相关规定，属于股票交易异常波动情形。 经公司董事会自查及发函问询控股股东、实际控制人，截 至本公告披露日，公司不存在应披露而未披露的重大信息。 相关媒体报道、市场传闻说明及风险提示：就目前市场上 较为关注的"麦角硫因"成分，公司销售的含有"麦角硫因"成 分的产品销售收入整体占比很低，对于公司整体日常经营及整体 业绩影响很小。公司敬请广大投资者注意二级市场交易风险，理 性决策，审慎投资。 证券代码：605136 证券简称：丽人丽妆 公告编号：2025-029 上海丽人丽妆化妆品股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担法律责任。 重要内容提示： 一、股票交易（异常）波动的具体情况 公司股票价格于 2025 年 5 月 15 日、5 月 16 日连续两个交 易日内日收盘价格涨幅偏离值累计超过 20% ...